Proteasome inhibition prevents experimentally-induced endothelial dysfunction
- 19 June 2009
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 84 (25-26), 929-934
- https://doi.org/10.1016/j.lfs.2009.04.016
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Targeting of the Proteasome Worsens Atherosclerosis?Circulation Research, 2008
- Chronic Proteasome Inhibition Contributes to Coronary AtherosclerosisCirculation Research, 2007
- Targeting Proteasome Worsens AtherosclerosisCirculation Research, 2007
- Effects of Proteasome Inhibition on the Kidney in Experimental HypercholesterolemiaJournal of the American Society of Nephrology, 2005
- Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2004
- Novel isoforms of NADPH oxidase in vascular physiology and pathophysiologyClinical and Experimental Pharmacology and Physiology, 2003
- Proteasome inhibitors: from research tools to drug candidatesCell Chemical Biology, 2001
- Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant StressCirculation Research, 2000
- Tumour necrosis factor α activates a p22phox-based NADH oxidase in vascular smooth muscleBiochemical Journal, 1998
- STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMESAnnual Review of Biochemistry, 1996